Hicks Derek
Insider CIK 1901282 · NTLA EVP, Chief Business Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NTLA Intellia Therapeutics, Inc | S Sale | 2025-01-03 | 2025-01-07 | 6,502 | $12.18 | $79.2K | 59,878 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2024-03-01 | 2024-03-05 | 42,421 | — | $0 | 42,421 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award | 2024-03-01 | 2024-03-05 | 29,393 | — | $0 | 66,380 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2024-01-03 | 2024-01-05 | 3,877 | $29.46 | $114.2K | 36,987 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2023-03-01 | 2023-03-03 | 33,287 | — | $0 | 33,287 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award | 2023-03-01 | 2023-03-03 | 23,558 | — | $0 | 40,864 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2023-01-04 | 2023-01-06 | 1,812 | $37.21 | $67.4K | 17,306 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2022-01-03 | 2022-01-05 | 25,000 | — | $0 | 25,000 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award | 2022-01-03 | 2022-01-05 | 19,118 | — | $0 | 19,118 | SEC↗ |